The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study
In a selected group of stable ambulatory advanced HF (left ventricular ejection fraction ≤35%, New York Heart Association Classes III and IV) patients, repetitive levosimendan 24 h infusion might be an additional therapeutic option but observed deaths may raise its safety issue.
Authors
- Agnieszka Tycińska (ORCID: https://orcid.org/0000-0001-7855-7261)
- Ewelina Kazimierczyk
- Agata Bielecka‐Dąbrowa (ORCID: https://orcid.org/0000-0001-6666-3999)
- Mariusz Gąsior (ORCID: https://orcid.org/0000-0001-6775-1392)
- Remigiusz Kazimierczyk (ORCID: https://orcid.org/0000-0003-4517-1498)
- Ewelina Rogalska
- Marek Gierlotka (ORCID: https://orcid.org/0000-0001-5639-2128)
- Klaudia Mickiewicz (ORCID: https://orcid.org/0000-0002-6474-766X)
- Agnieszka Pawlak (ORCID: https://orcid.org/0000-0001-9032-9130)
- Anna Szyszkowska
- Franciszek Kukliński
- Jacek Kubica
- Ł Szarpak
- A Południewska
- W Wojakowski
- J D Kasprzak
- P Leszek
- M Jaguszewski
- A Imiela
- J Nessler
- T Fernandez-Moreno
- E Straburzynska-Migaj
Institutions
- John Paul II Catholic University of Lublin (PL)
- Poznan University of Medical Sciences (PL)
- Jagiellonian University (PL)
- Medical University of Białystok (PL)
- Medical University of Silesia (PL)
- University of Opole (PL)
- Medical University of Warsaw (PL)
- Nicolaus Copernicus University (PL)
- Memorial Hospital (US)
- Medical University of Lodz (PL)
- Ministry of Interior (IT)
- Ministry of Interior and Administration (PL)
- Institute of Cardiology (PL)
- Polish Mother’s Memorial Hospital Research Institute (PL)
- Ministerio del Interior (ES)
- Lux Research (United States) (US)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1093/eschf/xvag021
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00